Here are three things to know about the request.
1. CVS Health inked a definitive merger agreement to acquire all outstanding shares of Aetna for roughly $69 billion in cash and stock Dec. 3. CVS Health filed its premerger notification and report to the DOJ and Federal Trade Commission Jan. 2.
2. The deal remains subject to approval from CVS Health and Aetna shareholders. Last month, an Aetna shareholder filed a proposed class-action lawsuit against the company and several of its executives and board members. The lawsuit alleges Aetna tried to convince its shareholders to vote in favor of the CVS Health transaction by filing a form containing “materially incomplete and misleading” information with the SEC on Jan. 4.
3. CVS Health and Aetna will each seek stockholder and shareholder approval on March 20. The companies still expect the deal to close in the second half of 2018.
More articles on payer issues:
CMS proposes 1.84% payment increase for Medicare Advantage plans: 3 things to know
Cigna’s Q4 profits fall 30.4%, but FY net income up: 4 things to know
Anthem Q4 profits surpass $1B after one-time tax benefit: 3 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
